HUP9904049A3 - Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis - Google Patents
Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosisInfo
- Publication number
- HUP9904049A3 HUP9904049A3 HU9904049A HUP9904049A HUP9904049A3 HU P9904049 A3 HUP9904049 A3 HU P9904049A3 HU 9904049 A HU9904049 A HU 9904049A HU P9904049 A HUP9904049 A HU P9904049A HU P9904049 A3 HUP9904049 A3 HU P9904049A3
- Authority
- HU
- Hungary
- Prior art keywords
- osteoporosis
- coherence
- cyclic
- treatment
- growth hormone
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 230000000123 anti-resoprtive effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK62396 | 1996-05-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9904049A2 HUP9904049A2 (en) | 2000-04-28 |
| HUP9904049A3 true HUP9904049A3 (en) | 2000-07-28 |
Family
ID=8095682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9904049A HUP9904049A3 (en) | 1996-05-31 | 1997-05-29 | Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0907374A1 (en) |
| JP (1) | JP2000512274A (en) |
| KR (1) | KR20000016204A (en) |
| CN (1) | CN1220609A (en) |
| AU (1) | AU3025997A (en) |
| BR (1) | BR9709499A (en) |
| CA (1) | CA2257174A1 (en) |
| CZ (1) | CZ383298A3 (en) |
| HU (1) | HUP9904049A3 (en) |
| IL (1) | IL126983A0 (en) |
| NO (1) | NO985573L (en) |
| PL (1) | PL330239A1 (en) |
| WO (1) | WO1997046252A1 (en) |
| ZA (1) | ZA974785B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1996000101A (en) | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
| GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
| EP1093463A1 (en) * | 1998-06-09 | 2001-04-25 | Novo Nordisk A/S | A method for preparing a compound with growth hormone releasing properties |
| US6784158B1 (en) | 1998-06-09 | 2004-08-31 | Novo Nordisk A/S | Method for preparing a compound with growth hormone releasing properties |
| JP2001031635A (en) | 1999-07-14 | 2001-02-06 | Ajinomoto Co Inc | Production of optically active n-protected-n-methyl- phenylalanine derivative |
| ATE446758T1 (en) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | USE OF GROWTH HORMONE SECRETAGOGENES TO PROMOTE DIGESTIVE MOTILITY |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| EP2118080B1 (en) | 2007-02-09 | 2016-08-31 | Ocera Therapeutics, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ236618A (en) * | 1990-01-03 | 1997-06-24 | Ciba Geigy Ag | Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound |
| JP2557779B2 (en) * | 1990-11-26 | 1996-11-27 | アール． レッカー，ロバート | Two-component drug for osteoporosis |
| PL314003A1 (en) * | 1993-10-19 | 1996-08-05 | Merck & Co Inc | Combination of bisulphonates and substances enhancing secretion of growth hormone |
-
1997
- 1997-05-29 HU HU9904049A patent/HUP9904049A3/en unknown
- 1997-05-29 CN CN97195144A patent/CN1220609A/en active Pending
- 1997-05-29 JP JP10500108A patent/JP2000512274A/en active Pending
- 1997-05-29 AU AU30259/97A patent/AU3025997A/en not_active Abandoned
- 1997-05-29 WO PCT/DK1997/000239 patent/WO1997046252A1/en not_active Application Discontinuation
- 1997-05-29 EP EP97924934A patent/EP0907374A1/en not_active Withdrawn
- 1997-05-29 CA CA002257174A patent/CA2257174A1/en not_active Abandoned
- 1997-05-29 IL IL12698397A patent/IL126983A0/en unknown
- 1997-05-29 PL PL97330239A patent/PL330239A1/en unknown
- 1997-05-29 BR BR9709499A patent/BR9709499A/en not_active Application Discontinuation
- 1997-05-29 CZ CZ983832A patent/CZ383298A3/en unknown
- 1997-05-29 KR KR1019980709772A patent/KR20000016204A/en not_active Application Discontinuation
- 1997-05-30 ZA ZA9704785A patent/ZA974785B/en unknown
-
1998
- 1998-11-27 NO NO985573A patent/NO985573L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA974785B (en) | 1998-01-22 |
| IL126983A0 (en) | 1999-09-22 |
| AU3025997A (en) | 1998-01-05 |
| CA2257174A1 (en) | 1997-12-11 |
| CZ383298A3 (en) | 1999-07-14 |
| KR20000016204A (en) | 2000-03-25 |
| CN1220609A (en) | 1999-06-23 |
| NO985573L (en) | 1999-01-29 |
| EP0907374A1 (en) | 1999-04-14 |
| JP2000512274A (en) | 2000-09-19 |
| PL330239A1 (en) | 1999-05-10 |
| WO1997046252A1 (en) | 1997-12-11 |
| HUP9904049A2 (en) | 2000-04-28 |
| NO985573D0 (en) | 1998-11-27 |
| BR9709499A (en) | 1999-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0767624A4 (en) | Devices and methods for bone/tissue preparation | |
| ZA9510147B (en) | Hard tissue bone cements and substitutes | |
| AU3021897A (en) | Bone prosthesis fixation device and methods of using same | |
| IL133864A0 (en) | Combination distraction dental implant and method of use | |
| HK1030545A1 (en) | Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture | |
| PL339449A1 (en) | Treatment of bone fractures involving the use of pthrp analogues | |
| EP0741548A4 (en) | Devices and methods for posterior spinal fixation | |
| AU5799099A (en) | Method and devices for use in bone fixation procedures | |
| EP0675700A4 (en) | Spinal treatment and long bone fixation apparatus and method. | |
| AU1917295A (en) | Bone and tissue lengthening device | |
| HU9401798D0 (en) | Methods for the treatment of osteoporosis using bisphonates and parathyroid hormone | |
| DE69307220D1 (en) | Vertebra fixation and restoration system | |
| IL113399A0 (en) | Human bone stimulating factor | |
| ZA9810247B (en) | Improved apparatus and method for micro-abrasions of human tissue and/or hides | |
| ZA9610901B (en) | Treatment and prophylaxis of osteoporosis | |
| HUP9904049A3 (en) | Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis | |
| EP0424159A3 (en) | Aseptic processing of allograft bone and tissue | |
| MX9703944A (en) | Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis. | |
| GB9421362D0 (en) | Orthopaedic human bone demonstational aid | |
| GB9321341D0 (en) | Therapeutic compositions for use in the treatment of skin lesions and method of making same | |
| EP0779812A4 (en) | Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone | |
| EP1009433A4 (en) | Therapeutic composition and method of treatment | |
| IL114063A0 (en) | Solution comprising IGF-I or any functional analogue thereof and method for its preparation | |
| IL120243A0 (en) | Bone fixation and stabilization device and method of using same | |
| ZA961859B (en) | Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |